LAUREN LU: Open Payments
NPI 1780302968 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 19 payments from 7 companies in 2025. Trend: 2023 $776 · 2024 $1,077 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $169 |
| GENZYME CORPORATION | 2 | $40 |
| Celltrion USA Inc. | 2 | $39 |
| Digestive Care, Inc. | 1 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Ardelyx, Inc. | 1 | $16 |
Products named: RINVOQ, DUPIXENT, SKYRIZI, VEGZELMA, Pertzye, XIFAXAN, IBSRELA.
Industry payments across MD — which companies pay providers there.
